Photo from Dana-Farber’s Breast Oncology Center/X
May 15, 2024, 15:58
Guidelines on the use of Bone Modifying Agents in Patients with Breast Cancer – DFCI Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X:
“Our consensus-based treatment guidelines on the use of Bone Modifying Agents in Patients with Breast Cancer are now up, check them out here.” .
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 15:20
Jan 15, 2025, 15:18
Jan 15, 2025, 15:12
Jan 15, 2025, 15:10
Jan 15, 2025, 15:06
Jan 15, 2025, 14:33
Jan 15, 2025, 14:27